And one more! After being approved by the European Medicines Agency on Thursday March 11 and by the Haute Autorité de Santé on Friday March 12, drugmaker Johnson & Johnson is to complete first deliveries to EU this April 19, 2021, to be then distributed all over the continent.
The vaccine filed approval for marketing authorization back to mid-February. This is the fourth vaccine that applied to authorization in Europe. Single-shot, it is to be stored at temperatures similar to the AstraZeneca vaccine and does not require special storage material.
As for vaccine approval, members of the European regulator stated that they “could issue an opinion by the middle of March 2021, provided the company’s data on the vaccine’s efficacy, safety and quality are sufficiently comprehensive and robust”. They added the vaccine has been submitted since December 1, 2020 to continuous assessment at the same time it completes clinical trials.
As for Europe, the initiative has been hailed. Ursula von der Leyen stated the European Union “The EU Commission will be ready to grant authorization as soon as EMA delivers a positive scientific opinion. More safe and effective vaccines are on their way”. It is expected to accelerate the ongoing European vaccination campaigns. All in all, the EU has so far ordered 200 million doses of the Johnson & Johnson vaccine, and potentially 200 million more.